EHA 2022 | RBP dysregulation and bone marrow failure: implications for future research
Pedro Aguilar-Garrido
• 20 Jun 2022
Pedro Aguilar-Garrido, Spanish National Cancer Research Center (CNIO), Madrid, Spain, briefly explains how a better understanding of novel mechanisms behind bone marrow failure, such as RNA binding protein (RBP) dysregulation, may have wider implications in other disease areas. This press briefing was recorded at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.
